Renal Denervation in Patients With Advanced Heart Failure

NCT01538992 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2013-07-24

No results posted yet for this study

Summary

Sympathetic system has important role occurrence of symptoms in heart failure. Renal denervation that is ablated some of sympathetic nerves is affected pathology of heart failure. This interventional therapy improves symptoms and life quality.

Conditions

Interventions

DEVICE

Standard steerable Marinr RF ablation Catheter (5F or 7F)

Intervention: Device: Standard steerable Mariner Radiofrequency ablation Catheter (5F or 7F)

Sponsors & Collaborators

  • Bursa Postgraduate Hospital

    lead OTHER

Principal Investigators

  • HASAN ARI, MD · Bursa Postgraduate Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-01-31
Completion
2014-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01538992 on ClinicalTrials.gov